Table 1.
Compd | R1 | R2 | R3 | TRPC6 IC50(?M)a |
---|---|---|---|---|
4a | MeNHCS | F | H | >130 |
4b | MeCO | F | H | >130 |
4c | Me(CH2)7CH=CH(CH2)7CO | F | H | NA |
4d | BocNH(CH2)2CO | F | H | NA |
4e | F | H | NA | |
4f | F | H | ~100 | |
4g | Ph2CHCO | F | H | ~100 |
4h | F | H | NA | |
4o | EtOCO | F | H | 4.7 ± 0.03b |
5a | Boc | F | H | 8.4 ± 1.1 |
5b | Boc | Cl | H | NA |
5c | Boc | CF3 | H | NA |
14a | EtOCO | CF3 | Me | 1.0 ± 0.3 |
14b | Boc | NO2 | Me | agonistc |
14c | F | Me | NA | |
14d | F | Me | NA | |
14e | F | Me | NA | |
14f | F | Me | NA | |
14g | F | Me | NA |
Effects on TRPC6 or IC50 against activation by 10 μM 4o, estimated based on one experiment with triplicates.
EC50 determined based on Ca2+ assay.
EC50 cannot be accurately determined because of the self-fluorescence of the compound, NA: No activity.